arrow
O

Omar P. Vallejos

Pontificia Universidad Catolica de Chile
H指数:14
被引数:792

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Transport Media on IL-33 Levels in Samples From Patients With Viral Respiratory Infections

运输介质对病毒性呼吸道感染患者样本中IL-33水平的影响

2026-10-070
OAAI
Vitamin D in mucosal healing: therapeutic potential and current evidence in inflammatory bowel disease

维生素D在黏膜愈合中的作用:炎症性肠病中的治疗潜力与当前证据

2026-07-310
PRE
Carbon monoxide-producing probiotic Escherichia coli attenuates HSV-1 skin disease

产一氧化碳益生菌大肠杆菌减轻HSV-1皮肤疾病

2026-05-010
OAAI
Human metapneumovirus respiratory infection affects both innate and adaptive intestinal immunity
2024-02-021
OAAI
SEN1990 is a predicted winged helix-turn-helix protein involved in the pathogenicity of Salmonella enterica serovar Enteritidis and the expression of the gene oafB in the SPI-17

SEN1990是一种预测的有翼螺旋-转角-螺旋蛋白,与肠道沙门氏菌血清型肠炎的致病性和oafB基因在SPI-17中的表达有关。

2023-11-030
OAAI
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial

在一项随机3期临床试验中,两种预防接种方案使用灭活SARS-CoV-2疫苗引起的免疫反应差异

2022-10-139
OAAI
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
MBIO
IF4.7
2022-08-3033
OAAI
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine

SARS-CoV-2灭活疫苗诱导的抗体和T细胞识别相关变异

2021-11-0959
OAAI
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
2021-09-2951
OAAI
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile
2021-09-1977
OA